ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us and our hands-on approach to production and development that sets us apart. If you are looking for a dynamic, innovative, growing company in the biopharmaceutical industry that is committed to excellence and integrity, then consider ADMA Biologics. We currently have an exciting opportunity available for a Supervisor, Operations in Goose Creek, SC!
The Supervisor, Operations, must be competent in all aspects of the ADMA BioCenters operations. They will be required to be certified and become preceptors in each work area. The Supervisor, Operations will also supervise and train employees in each work area. They will assist with the supervision of all activities executed within the plasma collection centers as assigned by the Director, Center Operations or Manager, Center Quality. These responsibilities include, but are not limited to plasma production, quality assurance, and human resource management. In the absence of senior center management members this position oversees all activities within the site, otherwise it is 100% working in their primary supervisory role.
The Supervisor, Operations will work with other ADMA team members to create an environment of teamwork and mutual respect between staff members. This position will work to ensure donor satisfaction is maximized with the intent of providing a safe, healthy, and friendly environment for both donors and staff.
Education Requirements: High school diploma or equivalent required.
Experience Requirements: Entry level management position, minimal experience is required.
In addition to competitive compensation, we offer a comprehensive benefits package including:
ADMA Biologics uses E-Verify to confirm the employment eligibility of all newly hired employees. To learn more about E-Verify, including your rights and responsibilities, please visit www.dhs.gov/E-Verify.

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.